孤立性产时发热与临床绒毛膜羊膜炎孕妇的抗生素治疗:母儿结局比较
这项为期10年的回顾性研究纳入≥34周单胎、体温≥38.0℃的临产孕妇,比较孤立性产时发热(接受静脉氨苄西林,n=227)与临床绒毛膜羊膜炎(接受静脉氨苄西林联合庆大霉素,n=231)的母儿感染结局。孤立性产时发热组产褥期子宫内膜炎、早发型败血症、绒毛膜羊膜拭子阳性及耐氨苄西林大肠埃希菌比例均更高。作者认为单用氨苄西林可能促进耐药大肠埃希菌生长,应考虑广谱抗生素。
要点
- 孤立性产时发热组产褥期子宫内膜炎3.9% vs 临床绒毛膜羊膜炎组8.8%(P=.03)。
- 孤立性产时发热组新生儿早发型败血症0.4% vs 临床绒毛膜羊膜炎组4.4%(P=.005)。
- 多因素分析中孤立性产时发热单用氨苄西林者子宫内膜炎OR 2.65、早发型败血症OR 8.33。
核心结论
- 产时发热无论是否伴其他感染征象,母儿并发症风险均升高。
- 孤立性产时发热单用氨苄西林可能促进绒毛膜羊膜耐氨苄西林大肠埃希菌生长,进而导致产褥期子宫内膜炎和早发型败血症。
- 在此背景下应考虑广谱抗生素。
研究设计与样本
- 为期10年的回顾性研究,纳入本院≥34周单胎、体温≥38.0℃的临产孕妇,共458例。
- 按本科室方案,孤立性产时发热者接受静脉氨苄西林(n=227),临床绒毛膜羊膜炎者接受静脉氨苄西林联合庆大霉素(n=231)。
- 主要结局为产褥期子宫内膜炎,并建立2个多因素logistic回归模型分别预测产褥期子宫内膜炎和新生儿早发型败血症。
主要发现
- 孤立性产时发热组 vs 临床绒毛膜羊膜炎组:产褥期子宫内膜炎3.9% vs 8.8%(P=.03),早发型败血症0.4% vs 4.4%(P=.005)。
- 孤立性产时发热组 vs 临床绒毛膜羊膜炎组:绒毛膜羊膜拭子阳性46.3% vs 63.9%(P<.001),耐氨苄西林大肠埃希菌35.5% vs 48.9%(P=.033)。
- 两组B族链球菌阳性绒毛膜羊膜拭子比例相似。
- B族链球菌阴性或未知亚组中,孤立性产时发热组 vs 疑似绒毛膜羊膜炎组:产褥期子宫内膜炎8.7% vs 3.3%(P=.041),新生儿早发型败血症4.1% vs 0%(P<.001)。
- 多因素模型中,孤立性产时发热单用氨苄西林 vs 临床绒毛膜羊膜炎用氨苄西林联合庆大霉素:子宫内膜炎OR 2.65(95%CI 1.06-6.62;P=.036),新生儿早发型败血症OR 8.33(95%CI 1.04-60.60;P=.045)。
关键数值与推荐
- 临床绒毛膜羊膜炎定义为孕妇发热≥38℃并至少满足2项临床征象:孕妇心动过速>100次/分、胎儿心动过速>160次/分、孕妇白细胞增多>15,000/mm2、脓性阴道分泌物、子宫压痛。
临床怎么用
- 作者认为,在此背景下应考虑广谱抗生素。
- 本研究中心的做法是孤立性产时发热者给予静脉氨苄西林,临床绒毛膜羊膜炎者给予静脉氨苄西林联合庆大霉素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Clinical chorioamnionitis refers to the presence of maternal fever (≥38°C) and at least 2 clinical signs: (1) maternal tachycardia (>100 bpm), (2) fetal tachycardia (>160 bpm), (3) maternal leukocytosis >15,000/mm2, (4) purulent vaginal discharge, and (5) uterine tenderness. Few data exist to guide the appropriate management of women with isolated intrapartum fever in the absence of other clinical signs suggesting chorioamnionitis. OBJECTIVE: This study compared maternal and neonatal infectious outcomes and microbiological outcomes between women with isolated intrapartum fever and women with clinical chorioamnionitis. STUDY DESIGN: This 10-year retrospective study included all the laboring women at our institution, at ≥34 weeks of gestation, with a singleton pregnancy and body temperature of ≥38.0°C, with or without other evidences of infection. According to our department protocol, women with isolated intrapartum fever received intravenous ampicillin, whereas women with clinical chorioamnionitis received intravenous ampicillin plus gentamicin. The primary outcome was puerperal endometritis, compared between women with isolated intrapartum fever (treated with ampicillin) and women with clinical chorioamnionitis (treated with ampicillin plus gentamicin). The secondary maternal outcomes consisted of (1) maternal clinical outcomes, such as cesarean delivery, surgical site infection, postpartum hemorrhage, and postpartum length of stay, and (2) microbiological studies, including positive chorioamniotic membrane swabs and blood culture. Among the secondary neonatal outcomes were early-onset sepsis, neonatal intensive care unit admission, and length of stay. Of note, 2 multivariate logistic regression models were created. A model aimed to predict puerperal endometritis controlled for gestational age of >41 weeks, diabetes mellitus, obesity, positive group B streptococcus status, rupture of membrane ≥18 hours, meconium staining, positive chorioamniotic membrane swabs, cesarean delivery, and empiric postdelivery antibiotic administration. A model aimed to predict neonatal early-onset sepsis controlled for gestational age of 34 to 37 weeks, positive group B streptococcus status, rupture of membrane ≥18 hours, and positive chorioamniotic membrane swabs. RESULTS: Overall, 458 women met the inclusion criteria. Compared with women with clinical chorioamnionitis (n=231), women with isolated intrapartum fever (n=227) had higher rates of puerperal endometritis (3.9% vs 8.8%; P=.03), early-onset sepsis (0.4% vs 4.4%; P=.005), positive chorioamniotic membrane swabs (46.3% vs 63.9%; P<.001), and ampicillin-resistant Escherichia coli (35.5% vs 48.9%; P=.033). The rate of group B streptococcus-positive chorioamniotic membrane swabs was similar between the groups. In a subanalysis of women with negative or unknown group B streptococcus status, the puerperal endometritis and neonatal early-onset sepsis rates were higher among women with isolated intrapartum fever than women with suspected chorioamnionitis (8.7% vs 3.3% [P=.041] and 4.1% vs 0% [P<.001], respectively). In 2 multivariate analysis models, among women with isolated intrapartum fever treated with ampicillin compared with those with clinical chorioamnionitis treated with ampicillin and gentamicin, the odds ratio of antibiotic treatment of endometritis was 2.65 (95% confidence interval, 1.06-6.62; P=.036), and the odds ratio of neonatal early-onset sepsis was 8.33 (95% confidence interval, 1.04-60.60; P=.045). CONCLUSION: Women with intrapartum fever, with or without other signs of infection, were at increased risk of maternal and neonatal complications. The use of ampicillin as a sole agent in isolated intrapartum fever might promote ampicillin-resistant E coli growth in the chorioamniotic membranes and consequently lead to puerperal endometritis and early-onset sepsis. In this context, a broad-range antibiotic should be considered.
引用
- Abu Shqara R, Glikman D, Jad S, et al. Antibiotic treatment of women with isolated intrapartum fever vs clinical chorioamnionitis: maternal and neonatal outcomes. Am J Obstet Gynecol. 2023. PMID: 38051599. doi:10.1016/j.ajog.2023.05.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。